THE COCHRANE COLLABORATION

Company number 03044323 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Overview

Company type
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Incorporated
1995-04-10
Registered office
11-13 Cavendish Square, London, England, W1G 0AN
Postcode
W1G 0AN
Accounts category
Group

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-04-10
Next due by
2027-04-24
View filing history →

Nature of business (SIC)

  • 86900 Other human health activities

Officers 11 current · 125 resigned

Subscribers only Director
Subscribers only Appointed 2026-11-10
Subscribers only Secretary
Appointed 2026-06-01
Subscribers only Director
Appointed 2024-11-25
Subscribers only Director
Appointed 2024-11-25
Subscribers only Director
Appointed 2024-11-25

View all officers and resignations →

Group structure 1 subsidiary

From persons-with-significant-control filings on the public register.

Registered charity

THE COCHRANE COLLABORATION — charity number 1045921

Registered 1995-04-26 Income £11,093,599 Spending £11,911,681 FY to 2025-12-31

Source: Charity Commission for England and Wales, Open Government Licence v3.0.

Data protection registration

Registered with the ICO as a data protection fee payer — Z4681494 (Tier 1), registered since 2000.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
http://www.cochrane-collaboration.org

Previous registered addresses 1

AddressChanged on
SUMMERTOWN PAVILION, 18-24 MIDDLE WAY, OXFORD, OX2 7LG2015-01-30

Among its peers

Among the oldest 25%

of 1,917 similar companies in W, trading since 1995

The class of 1995

48%

of the 235 companies in this sector incorporated in 1995 are still active today; 51% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →